Haoxi Health Technology (HAO) Current Deferred Revenue (2023 - 2025)

Haoxi Health Technology's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $669365.0 for Q4 2025.

• In Q4 2025, Current Deferred Revenue rose 247.55% year-over-year to $669365.0; the TTM figure through Dec 2025 stood at $669365.0 (up 247.55% YoY), while the FY2025 annual figure was $537646.0, down 54.63% from the prior year.
• Current Deferred Revenue was $669365.0 for Q4 2025 at Haoxi Health Technology, up from $537646.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.5 million in Q2 2023 to a low of -$488561.0 in Q4 2023.
• Historically, Current Deferred Revenue has averaged $490646.5 across 3 years, with a median of $603505.5 in 2025.
• Biggest YoY gain for Current Deferred Revenue was 247.55% in 2025; the steepest drop was 54.63% in 2025.
• A 3-year view of Current Deferred Revenue shows it stood at -$488561.0 in 2023, then increased by 7.15% to -$453648.0 in 2024, then soared by 247.55% to $669365.0 in 2025.
• The last three Current Deferred Revenue figures came in at $669365.0 (Q4 2025), $537646.0 (Q2 2025), and -$453648.0 (Q4 2024), per Business Quant data.